Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
(2024) reported that neither semaglutide nor the dual GIP/GLP-1 agonist tirzepatide influenced disease-related pathology, behavior, or cognitive function in 5XFAD and APP/PS1 mouse models of Alzheimers disease when administered after the establishment of pathology (Forny Germano et al., 2024)
You deserve long-lasting relief and real results
The discontinuation of liraglutide after 12 weeks 31 and semaglutide after 26 weeks 35 of treatment demonstrated, on average, a regain of 47% and 43% of the weight lost at the end of the active treatment period, respectively
At Spa26, our Doctor-First protocol requires a high-protein diet (1.21.5g per kg of body weight) and consistent resistance training
In plain terms, microdosing GLP-1 means using the smallest effective dose to support metabolic health, blood sugar regulation, and appetite signaling without pushing the body into rapid or dramatic weight loss
